Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization

Adeno-associated viruses (AAV) are among the foremost vectors for in vivo gene therapy. A number of monoclonal antibodies against several serotypes of AAV have previously been prepared. Many are neutralizing, and the predominant mechanisms have been reported as the inhibition of binding to extracell...

Full description

Bibliographic Details
Main Authors: Edward E. Large, Michael S. Chapman
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1116896/full
_version_ 1811167235964665856
author Edward E. Large
Michael S. Chapman
author_facet Edward E. Large
Michael S. Chapman
author_sort Edward E. Large
collection DOAJ
description Adeno-associated viruses (AAV) are among the foremost vectors for in vivo gene therapy. A number of monoclonal antibodies against several serotypes of AAV have previously been prepared. Many are neutralizing, and the predominant mechanisms have been reported as the inhibition of binding to extracellular glycan receptors or interference with some post-entry step. The identification of a protein receptor and recent structural characterization of its interactions with AAV compel reconsideration of this tenet. AAVs can be divided into two families based on which domain of the receptor is strongly bound. Neighboring domains, unseen in the high-resolution electron microscopy structures have now been located by electron tomography, pointing away from the virus. The epitopes of neutralizing antibodies, previously characterized, are now compared to the distinct protein receptor footprints of the two families of AAV. Comparative structural analysis suggests that antibody interference with protein receptor binding might be the more prevalent mechanism than interference with glycan attachment. Limited competitive binding assays give some support to the hypothesis that inhibition of binding to the protein receptor has been an overlooked mechanism of neutralization. More extensive testing is warranted.
first_indexed 2024-04-10T16:05:53Z
format Article
id doaj.art-598c3186f5d143258cddb7c1dcd0f34d
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-10T16:05:53Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-598c3186f5d143258cddb7c1dcd0f34d2023-02-10T05:27:21ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2023-02-011410.3389/fmicb.2023.11168961116896Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralizationEdward E. LargeMichael S. ChapmanAdeno-associated viruses (AAV) are among the foremost vectors for in vivo gene therapy. A number of monoclonal antibodies against several serotypes of AAV have previously been prepared. Many are neutralizing, and the predominant mechanisms have been reported as the inhibition of binding to extracellular glycan receptors or interference with some post-entry step. The identification of a protein receptor and recent structural characterization of its interactions with AAV compel reconsideration of this tenet. AAVs can be divided into two families based on which domain of the receptor is strongly bound. Neighboring domains, unseen in the high-resolution electron microscopy structures have now been located by electron tomography, pointing away from the virus. The epitopes of neutralizing antibodies, previously characterized, are now compared to the distinct protein receptor footprints of the two families of AAV. Comparative structural analysis suggests that antibody interference with protein receptor binding might be the more prevalent mechanism than interference with glycan attachment. Limited competitive binding assays give some support to the hypothesis that inhibition of binding to the protein receptor has been an overlooked mechanism of neutralization. More extensive testing is warranted.https://www.frontiersin.org/articles/10.3389/fmicb.2023.1116896/fulladeno-associated virusAAVRentryantibodygene therapystructure
spellingShingle Edward E. Large
Michael S. Chapman
Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
Frontiers in Microbiology
adeno-associated virus
AAVR
entry
antibody
gene therapy
structure
title Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
title_full Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
title_fullStr Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
title_full_unstemmed Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
title_short Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
title_sort adeno associated virus receptor complexes and implications for adeno associated virus immune neutralization
topic adeno-associated virus
AAVR
entry
antibody
gene therapy
structure
url https://www.frontiersin.org/articles/10.3389/fmicb.2023.1116896/full
work_keys_str_mv AT edwardelarge adenoassociatedvirusreceptorcomplexesandimplicationsforadenoassociatedvirusimmuneneutralization
AT michaelschapman adenoassociatedvirusreceptorcomplexesandimplicationsforadenoassociatedvirusimmuneneutralization